This inventor holds 1 USPTO granted patent. Top assignee: G.d. Searle & Company. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: David Paul Creely: Inventor in Biotechnology
Introduction
David Paul Creely is an inventor associated with O’Fallon, Missouri, and G. D. Searle & Company. His patent work concerns nucleic acids and expression vectors related to human leukotriene C₄ synthase.
Latest Patents
Creely is credited with 1 patent. The patent describes DNA sequences encoding human LTC₄ synthase and expression vectors containing those sequences. It also discusses using the DNA in assays to detect LTC₄ synthase inhibitors, along with nucleic acid probes and antisense oligonucleotides intended to identify or inhibit the enzyme.
Career Highlights
Creely’s documented patent contribution focuses on molecular biology and potential methods for studying and inhibiting LTC₄ synthase. The work connects genetic materials and expression systems with research applications.
Collaborations
The patent lists Scott David Hauser and Dean James Welsch among Creely’s coworkers. The work is associated with G. D. Searle & Company.
Conclusion
David Paul Creely’s recorded invention reflects a biotechnology-focused contribution involving human LTC₄ synthase, its genetic encoding, and tools for investigating the enzyme.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile